Insider Transactions in Q1 2026 at Celldex Therapeutics, Inc. (CLDX)
Insider Transaction List (Q1 2026)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 02
2026
|
Samuel Bates Martin SVP AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,817
+12.76%
|
$48,170
$10.38 P/Share
|